278 related articles for article (PubMed ID: 32649919)
21. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
24. Establishing a Cohort and a Biorepository to Identify Biomarkers for Early Detection of Lung Cancer: The Nashville Lung Cancer Screening Trial Cohort.
Lakhani DA; Chen SC; Antic S; Muterspaugh A; Cook C; Liu N; Shujat H; Jouan S; Winston B; Fields K; Wenstrup J; Block SL; Hinton A; Miller A; Atmajoana S; Helton JT; Patel K; Balar AB; Brewer K; Nag S; Singh R; Disher A; Huerta L; Fremont R; Rickman O; Chen H; Eisenberg R; Sandler KL; Paulson A; Walker RC; Shah C; Smith GT; Landman B; Deppen S; Grogan EL; Aldrich MC; Massion PP
Ann Am Thorac Soc; 2021 Jul; 18(7):1227-1234. PubMed ID: 33400907
[No Abstract] [Full Text] [Related]
25. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract][Full Text] [Related]
26. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
[TBL] [Abstract][Full Text] [Related]
27. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
[TBL] [Abstract][Full Text] [Related]
28. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
de-Torres JP; Wisnivesky JP; Bastarrika G; Wilson DO; Celli BR; Zulueta JJ
Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):36-41. PubMed ID: 32409195
[TBL] [Abstract][Full Text] [Related]
29. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
[TBL] [Abstract][Full Text] [Related]
30. Detection of Subsolid Nodules in Lung Cancer Screening: Complementary Sensitivity of Visual Reading and Computer-Aided Diagnosis.
Silva M; Schaefer-Prokop CM; Jacobs C; Capretti G; Ciompi F; van Ginneken B; Pastorino U; Sverzellati N
Invest Radiol; 2018 Aug; 53(8):441-449. PubMed ID: 29543693
[TBL] [Abstract][Full Text] [Related]
31. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
32. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
[TBL] [Abstract][Full Text] [Related]
33. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
34. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
[TBL] [Abstract][Full Text] [Related]
35. Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT).
Kummer S; Waller J; Ruparel M; Duffy SW; Janes SM; Quaife SL
Thorax; 2020 Dec; 75(12):1065-1073. PubMed ID: 33087548
[TBL] [Abstract][Full Text] [Related]
36. Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes.
Triphuridet N; Vidhyarkorn S; Worakitsitisatorn A; Sricharunrat T; Teerayathanakul N; Auewarakul C; Chungklay N; Krongthong W; Luengingkasoot S; Sornsamdang G; Patumanond J; Sritipsukho P
Lung Cancer; 2018 Aug; 122():243-248. PubMed ID: 30032839
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
[TBL] [Abstract][Full Text] [Related]
38. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository.
Crawford EL; Levin A; Safi F; Lu M; Baugh A; Zhang X; Yeo J; Khuder SA; Boulos AM; Nana-Sinkam P; Massion PP; Arenberg DA; Midthun D; Mazzone PJ; Nathan SD; Wainz R; Silvestri G; Tita J; Willey JC
BMC Pulm Med; 2016 Jan; 16():16. PubMed ID: 26801409
[TBL] [Abstract][Full Text] [Related]
40. Optimum diameter threshold for lung nodules at baseline lung cancer screening with low-dose chest CT: exploration of results from the Korean Lung Cancer Screening Project.
Hwang EJ; Goo JM; Kim HY; Yi J; Kim Y
Eur Radiol; 2021 Sep; 31(9):7202-7212. PubMed ID: 33738597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
